Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on "Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study"

• Published in: Clinical and molecular hepatology 2024, 30(4), , pp.974-977
• Main Authors: Zhu, Yixuan, Ma, Xiaoyan, Ni, Wenjing, Yeo, Yee Hui, Shi, Junping, Li, Jie
• Format: Article
• Language: English
• Subjects: Alcohol; Biopsy; Body mass index; Diabetes; fatty liver; Hepatology; High density lipoprotein; Hospitals; Hypertension; Infectious diseases; Letter to the Editor; Liver diseases; Metabolism; Mortality; nafld; Obesity; Overweight; predictive value of tests; Risk factors; Ultrasonic imaging; 내과학
• ISSN: 2287-2728; 2287-285X; 2287-285X
• DOI: 10.3350/cmh.2024.0417

According to the National Death Index (NDI), we defined individuals with death from heart disease as those with cardiovascular-related mortality (Supplementary Methods), which is the most common cause-specific mortality for NAFLD [6]. [...]we focused only on mortality rates due to the lack of disease incidence data. Fourthly, the study cohort, enrolled over three decades ago, may not represent the current population. [...]prospective studies should track the long-term outcomes of MASLD patients using more precise diagnostic tools and novel longitudinal cohort studies. [...]our study suggested that NAFLD and MASLD have similar predictive power, whereas MAFLD is less effective in predicting all-cause and cardiovascular-related mortality.